Psoriasis
Michael Peter Schön, Wolf‐Henning Boehncke · New England Journal of Medicine · 2005
Research to define the pathogenesis of psoriasis, a common inflammatory skin disorder, has considerably increased the general understanding of T-cell–mediated autoimmune disorders. Psoriasis is increasingly a prime target for new pathogenesis-oriented biologic therapies. The authors of this article review genetic, clinical, and pathogenic aspects of psoriasis and discuss their implications for new therapies.
Cited by 955 works. doi:10.1056/nejmra041320
Authors
References
- Lymphocyte Homing and Homeostasis
- The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
- Psoriasis causes as much disability as other major medical diseases
- Etanercept as Monotherapy in Patients with Psoriasis
- Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
- T-Cell Function and Migration — Two Sides of the Same Coin
- Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).
- Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris
- The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
- Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin